BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Ubago, R. [1 ]
Castillo, M. A. [1 ]
Flores, S. [2 ]
Beltran, C. [1 ]
机构：
[1] Agencia Evaluac Tecnol Sanitarias Andalucia, Seville, Andalucia, Spain
[2] Andalusian Agcy Hlth & Technol Assessment, Seville, Andalucia, Spain
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1112
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A435 / A435
页数：1
相关论文
共 50 条
  • [41] FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
    Loupakis, F.
    Cremolini, C.
    Salvatore, L.
    Masi, G.
    Sensi, E.
    Schirripa, M.
    Michelucci, A.
    Pfanner, E.
    Brunetti, I.
    Lupi, C.
    Antoniotti, C.
    Bergamo, F.
    Lonardi, S.
    Zagonel, V.
    Simi, P.
    Fontanini, G.
    Falcone, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) : 57 - 63
  • [42] Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    J Barriuso
    [J]. British Journal of Cancer, 2011, 104 : 226 - 226
  • [43] Effectiveness of Bevacizumab With First-Line Combination Chemotherapy for Medicare Patients With Stage IV Colorectal Cancer
    Meyerhardt, Jeffrey A.
    Li, Ling
    Sanoff, Hanna K.
    Carpenter, William
    Schrag, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 608 - 615
  • [44] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
    Antonuzzo, Lorenzo
    Giommoni, Elisa
    Pastorelli, Davide
    Latiano, Tiziana
    Pavese, Ida
    Azzarello, Domenico
    Aieta, Michele
    Pastina, Ilaria
    Di Fabio, Francesca
    Bertolini, Alessandro
    Corsi, Domenico Cristiano
    Mogavero, Selene
    Angelini, Valentina
    Pazzagli, Mario
    Di Costanzo, Francesco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7281 - 7288
  • [45] Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’
    M J Molina-Garrido
    C Guillén-Ponce
    [J]. British Journal of Cancer, 2011, 104 : 224 - 225
  • [46] Comment on 'Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'
    Molina-Garrido, M. J.
    Guillen-Ponce, C.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 224 - 225
  • [47] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer:The OBELIX study
    Lorenzo Antonuzzo
    Elisa Giommoni
    Davide Pastorelli
    Tiziana Latiano
    Ida Pavese
    Domenico Azzarello
    Michele Aieta
    Ilaria Pastina
    Francesca Di Fabio
    Alessandro Bertolini
    Domenico Cristiano Corsi
    Selene Mogavero
    Valentina Angelini
    Mario Pazzagli
    Francesco Di Costanzo
    [J]. World Journal of Gastroenterology, 2015, (23) : 7281 - 7288
  • [48] Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Barriuso, J.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 226 - 226
  • [49] NICE guidance on bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
    Umeweni, Nwamaka
    Nolan, Kay
    Knight, Helen
    Clark, Peter
    [J]. LANCET ONCOLOGY, 2012, 13 (10): : 977 - 978
  • [50] Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
    Dyar, Stephen
    Moreno-Aspitia, Alvaro
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 239 - 246
12345